Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study

BACKGROUND AND AIMS: To report 5‐year outcomes of the CERTITUDE study. METHODS: An observational study in patients with liver transplantation (LTx) compared the long‐term impact of immunosuppression (with/without a calcineurin inhibitor) on renal function, cancers, major cardiovascular events (MACEs...

Descripción completa

Detalles Bibliográficos
Autores principales: Saliba, Faouzi, Duvoux, Christophe, Dharancy, Sébastien, Dumortier, Jérôme, Calmus, Yvon, Gugenheim, Jean, Kamar, Nassim, Salamé, Ephrem, Neau‐Cransac, Martine, Vanlemmens, Claire, Durand, François, Pageaux, Georges‐Philippe, Hardwigsen, Jean, Benkhatar, Yasmina, Derquenne, François, Conti, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Cirrhosis, Liver Failure and Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826472/
https://www.ncbi.nlm.nih.gov/pubmed/35962772
http://dx.doi.org/10.1111/liv.15396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826472/
https://www.ncbi.nlm.nih.gov/pubmed/35962772
http://dx.doi.org/10.1111/liv.15396

Ejemplares similares